Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wunderink

Showing results (161-170 of 545) with videos related to

Pageof 55
Sort By:
Chest|February 1, 1992
Management of bacterial pneumonia in ventilated patients. Protected bronchoalveolar lavage as a diagnostic toolG U Meduri, R G Wunderink, K V Leeper, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2023
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosaOwen R Albin, Jason M Pogue, Richard G Wunderink, et al.
Chest|January 11, 1991
The diagnostic utility of the antibody-coated bacteria test in intubated patientsR G Wunderink, G B Russell, E Mezger, et al.
Chest|April 1, 1996
Ventilator-associated pneumonia due to Pseudomonas aeruginosaS Crouch Brewer, R G Wunderink, C B Jones, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2001
Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associationsG W Waterer, M W Quasney, R M Cantor, et al.
Pharmacotherapy|March 24, 2006
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumoniaMarc H Scheetz, Richard G Wunderink, Michael J Postelnick, et al.
BMC Health Services Research|July 17, 2012
Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysisCurtis H Weiss, Stephen D Persell, Richard G Wunderink, et al.
Seminars in Respiratory and Critical Care Medicine|January 16, 2023
Clinical Features of COVID-19 and Differentiation from Other Causes of CAPCatherine A Gao, Chiagozie I Pickens, Luisa Morales-Nebreda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumoniaJohn G Bartlett, Philip S Barie, Michael S Niederman, et al.
Critical Care Medicine|January 15, 2013
Bronchoalveolar lavage amylase is associated with risk factors for aspiration and predicts bacterial pneumoniaCurtis H Weiss, Farzad Moazed, David DiBardino, et al.
Pageof 55

Showing results (161-170 of 545) with videos related to

Sort By:
Pageof 55
Chest|February 1, 1992
Management of bacterial pneumonia in ventilated patients. Protected bronchoalveolar lavage as a diagnostic toolG U Meduri, R G Wunderink, K V Leeper, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2023
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosaOwen R Albin, Jason M Pogue, Richard G Wunderink, et al.
Chest|January 11, 1991
The diagnostic utility of the antibody-coated bacteria test in intubated patientsR G Wunderink, G B Russell, E Mezger, et al.
Chest|April 1, 1996
Ventilator-associated pneumonia due to Pseudomonas aeruginosaS Crouch Brewer, R G Wunderink, C B Jones, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2001
Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associationsG W Waterer, M W Quasney, R M Cantor, et al.
Pharmacotherapy|March 24, 2006
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumoniaMarc H Scheetz, Richard G Wunderink, Michael J Postelnick, et al.
BMC Health Services Research|July 17, 2012
Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysisCurtis H Weiss, Stephen D Persell, Richard G Wunderink, et al.
Seminars in Respiratory and Critical Care Medicine|January 16, 2023
Clinical Features of COVID-19 and Differentiation from Other Causes of CAPCatherine A Gao, Chiagozie I Pickens, Luisa Morales-Nebreda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumoniaJohn G Bartlett, Philip S Barie, Michael S Niederman, et al.
Critical Care Medicine|January 15, 2013
Bronchoalveolar lavage amylase is associated with risk factors for aspiration and predicts bacterial pneumoniaCurtis H Weiss, Farzad Moazed, David DiBardino, et al.
Pageof 55